| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-40 |
| filingDate |
2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ea3d32f6ed514285d99b690a27c5fd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1b7f9254ddfdaa4d15e55ad7df4e4cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ec0ac08d69f8de29d34f3f20acd8fce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27df5b05c54938c246743b203fa855db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0497bd445b2fbce8398ece57b4698b7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb336e814e6ad033c3670c28b09aa93 |
| publicationDate |
2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I691334-B |
| titleOfInvention |
Internally taken compositions, preparations, and uses |
| abstract |
The subject of the present invention is to find a composition for internal use that can exert a good fat reduction effect. That is, the present invention provides an internal administration composition containing component (a): lactoferrin and component (b): fucoxanthin and/or its metabolites. The ratio of component (b)/component (a) is preferably 0.0001 or more and less than 0.3. In addition, the present invention provides a body fat reducing agent that uses ingredient (a) and ingredient (b) as effective ingredients, a weight loss accelerator that uses ingredient (a) and ingredient (b) as effective ingredients, and ingredient (a) and The component (b) is a blood-neutral fat-reducing agent as an effective component, and a blood-free fatty acid-reducing agent that uses the components (a) and (b) as an effective component. |
| priorityDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |